BDX vs QDEL: fair value comparison
Becton, Dickinson and Company and QuidelOrtho Corporation · Updated 2026-09-07
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, QDEL currently sits closer to the top of our discount ranking. BDX carries the stronger quality grade.
| BDX | QDEL | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $184.74 | $17.71 |
| 12-month range | $145.33–$201.91 | $12.64–$31.25 |
| Sector rank | #53 of 113 Healthcare | #51 of 113 Healthcare |
| Quality grade | B | F |
| Leverage | Moderate | Moderate |
| Margin trend | Expanding | Expanding |
| Revenue growth | Modest | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Mixed |
| DCF cross-check | Undervalued | — |
| 52-week position | The upper-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: BDX fair value analysis · QDEL fair value analysis